Fig. 3From: EXTL3 could serve as a potential biomarker of prognosis and immunotherapy for prostate cancer and its potential mechanismsEXTL3-related signaling pathways: A calcium pathway; B chemokine pathway; C ERBB pathway; D JAK STAT pathway; E MAPK pathway; F WNT pathway; G oxidative phosphorylation pathway; H all of these seven pathwaysBack to article page